Related Experiment Video
Updated: Jun 23, 2025

06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.7K
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services:
Philip Todd Korthuis1,2, Kim Hoffman1,2, Adrianne R Wilson-Poe2,3
1Oregon Health & Science University, Portland, OR, USA.
Journal of Psychopharmacology (Oxford, England)
|June 18, 2024
Summary
Experts developed core measures for supervised psilocybin services to ensure safety and quality. These best practice guidelines will help monitor outcomes in community-based psychedelic therapy programs.
Area of Science:
- Psycho-pharmacology
- Clinical Psychology
- Public Health
Background:
- Voter initiatives in Oregon and Colorado have established legal frameworks for supervised psilocybin services.
- Current measures lack standardized methods for monitoring the safety and outcomes of these services.
Purpose of the Study:
- To develop a core set of best practice measures for supervised psilocybin services.
- Establish guidelines for assessing the quality, safety, and outcomes of psychedelic-assisted therapy.
Main Methods:
- A three-phase e-Delphi process involving 36 experts with extensive experience in psilocybin facilitation.
- Experts generated, rated, and refined measures for assessing processes, outcomes, and structure in psilocybin services.
- Measures were prioritized based on importance and feasibility through qualitative and quantitative analysis.
Main Results:
- 55 candidate measures were identified across process, outcome, and structure domains.
- A core set of 11 process, 11 outcome, and 17 structure measures were prioritized.
- These measures balance importance and feasibility for practical application in psilocybin services.
Conclusions:
- Standardizing these core measures is recommended for service providers and policymakers.
- Implementation will enhance the monitoring of safety, quality, and outcomes in community-based psilocybin services.
- This study provides a foundation for evidence-based practices in psychedelic-assisted therapy.
Related Concept Videos
Hallucinogens and Psychedelics
163
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
163
CNS Stimulants: Psychedelic Agents
146
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
146
Self-Help Support Groups
29
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
29

